tm logo
Trademark Search
ULIBDI

View On IC.GC.CA

ULIBDI
SEARCHED

on 29 Oct 2024

Last Applicant/ Owned by

Prometheus Biosciences, Inc.

3050 Science Park Rd.San Diego CA 92037

US

Serial Number

2269038 filed on 21st Feb 2023

Correspondent Address

Bay Adelaide Centre, East Tower22 Adelaide St. WestTORONTO

ONTARIO

CA

M5H4E3

ULIBDI

Trademark usage description

pharmaceutical preparations used for the treatment of gastrointestinal disorders and diseases, colitis, crohn's disease, inflammatory bowel disease, s Read More

Classification Information

Class [005]
Pharmaceutical preparations used for the treatment of gastrointestinal disorders and diseases, colitis, Crohn's disease, Inflammatory Bowel Disease, systemic sclerosis, Interstitial Lung Disease, Systemic sclerosis-associated interstitial lung disease, arthritis, and other diseases of the immune, digestive, bowel, skin, joint, lung, liver, kidney, bile duct, or gastrointestinal systems, immune modulation and management of side effects associated with renal disorders and cancer; diagnostic preparations for clinical or medical laboratory use; diagnostic reagents for clinical or medical laboratory use.

Classification kind code

12

Class [042]
Medical laboratory services, namely, laboratory testing, medical diagnostic testing, evaluation, and medical research services; medical laboratory services, namely, laboratory testing in the field of disease management and pathology and of patient diagnosis and patient selection.

Classification kind code

12

Class [044]
Disease management services namely medical analysis services for diagnostic and treatment purposes and managing patient data; medical services, namely, providing medical information to health care providers, managed care providers and patients via computer networks; providing health information in the field of gastrointestinal diseases, colitis, Crohn's disease, Inflammatory Bowel Disease, systemic sclerosis, Interstitial Lung Disease, Systemic sclerosis-associated interstitial lung disease, arthritis, and other diseases of the immune, digestive, bowel, skin, joint, lung, liver, kidney, bile duct, or gastrointestinal systems; providing information relating to medical diagnostic testing; providing information relating to treatment recommendation; medical consultation; providing information about services for the diagnosis, prevention, and treatment of gastrointestinal disorders and diseases, colitis, Crohn's disease, Inflammatory Bowel Disease, systemic sclerosis, Interstitial Lung Disease, Systemic sclerosis-associated interstitial lung disease, arthritis, and other diseases of the immune, digestive, bowel, skin, joint, lung, liver, kidney, bile duct, or gastrointestinal systems, immune modulation and management of side effects associated with renal disorders and cancer via a websiter.

Classification kind code

12

Mark Details

Serial Number

2269038

Mark Type

Trademark

Legal History

Action TakenStatus
Submitted for opposition 22
on 29th Oct 2024		Search Recorded
Submitted for opposition 20
on 29th Oct 2024		Examiner's First Report
Submitted for opposition 223
on 29th Oct 2024		Total Provisional Refusal
Submitted for opposition 256
on 13th May 2024		Notification of Possible Opposition Sent
Submitted for opposition 48
on 15th Mar 2024		Agent Changed
Submitted for opposition 257
on 13th Jul 2023		Designation Notification - Madrid Protocol
Submitted for opposition 31
on 12th Jul 2023		Formalized
Submitted for opposition 1
on 12th Jul 2023		Created
Submitted for opposition 228
on 21st Feb 2023		International Registration
Submitted for opposition 30
on 21st Feb 2023		Filed